Roche Q1 Sales 14.7bn Meet Forecast

Roche Holding AG reported Q1 group sales of CHF 14.7 billion, roughly in line with the CHF 14.8 billion consensus.
Pharmaceuticals division posted CHF 11.5 billion sales versus CHF 11.9 billion estimate; Diagnostics delivered CHF 3.3 billion, slightly below CHF 3.5 billion consensus.
Group sales grew 6% at constant exchange rates but fell 5% in Swiss francs; revenue rose 9% YoY in USD.
CEO Thomas Schinecker highlighted start, reaffirmed 2026 outlook of sales and EPS growth, and announced Phase III trial of oral GLP‑1 candidate CT‑996.